SC 13G: SOLENO THERAPEUTICS INC

AI Summary

SC 13G filing by SOLENO THERAPEUTICS INC.

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — nc. (Name of Issue r) Common Stock, $0.001 par value per share (Title of Class o

Filing Documents

• ea0213665-13gvivo_soleno.htm (SC 13G) — 87KB
• ea021366501ex99-1_soleno.htm (EX-99.1) — 5KB
• 0001213900-24-076217.txt ( ) — 94KB

Ownership

Item 4. Ownership. (a) and (b) Amount beneficially owned: The information set forth in rows 5 through 11 of the cover pages is incorporated by reference into this Item 4. (c) Number of shares as to which such person has: Reporting Person Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Percentage of Common Stock Outstanding Vivo Opportunity Fund Holdings, L.P. 6,291,851 0 6,291,851 0 16.2 %* Vivo Opportunity, LLC 6,291,851 0 6,291,851 0 16.2 %* * The percent of class was calculated based upon 38,871,594 shares of Common Stock of the Issuer outstanding as of August 2, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the SEC on August 7, 2024. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 5, 2024 VIVO OPPORTUNITY FUND HOLDINGS, L.P, By: Vivo Op